Strikingly, in vitro and in vivo study demonstrated that CHEK1 promoted MM cellular proliferation and evoked drug-resistance partially by increasing MM chromosomal instability (Gu et al., 2021). The gene discussed is CHEK1; the disease is Miyoshi myopathy.